Le Lézard
Classified in: Science and technology
Subject: EXE

Astronauts Safely in Orbit Following Launch to International Space Station


WASHINGTON, June 6, 2018 /PRNewswire-USNewswire/ -- Three crew members are on their way to the International Space Station after launching from the Baikonur Cosmodrome in Kazakhstan at 7:12 a.m. EDT Wednesday (5:12 p.m. Baikonur time).

NASA Logo. (PRNewsFoto/NASA) (PRNewsFoto/)

The Soyuz spacecraft carrying Serena Auñón-Chancellor of NASA, Alexander Gerst of ESA (European Space Agency), and Sergey Prokopyev of the Russian space agency Roscosmos is scheduled to dock to the space station's Rassvet module at 9:07 a.m. Friday, June 8. Coverage of docking will begin at 8:15 a.m. on NASA Television and the agency's website, followed at 10:30 a.m. by coverage of the opening of hatches between the spacecraft and station.

The arrival of Auñón-Chancellor, Gerst and Prokopyev will restore the station to six crew members. They will join Expedition 56 commander Drew Feustel and flight engineers Ricky Arnold of NASA and Oleg Artemyev of Roscosmos. The crew will spend more than five months conducting about 250 science investigations in fields such as biology, Earth science, human research, physical sciences and technology development.

Feustel, Arnold and Artemyev are scheduled to remain aboard the station until October, while Auñón-Chancellor, Gerst and Prokopyev are slated to return to Earth in December.

This crew continues the long-term increase in crew size on the U.S. segment from three to four, allowing NASA to maximize time dedicated to research on the space station. Highlights of upcoming investigations include a new facility to study ultra-cold quantum gases, the first commercial European facility to conduct microgravity research, and a system that uses surface forces to accomplish liquid-liquid separation.

For more than 17 years, humans have lived and worked continuously aboard the station, advancing scientific knowledge and demonstrating new technologies, making research breakthroughs not possible on Earth that will enable long-duration human and robotic exploration into deep space. A global endeavor, more than 230 people from 18 countries have visited the unique microgravity laboratory that has hosted more than 2,400 research investigations from researchers in more than 103 countries.

Get breaking news, images and features from the station on Instagram and Twitter.

This is the first spaceflight for Auñón-Chancellor, who was selected as an astronaut in 2009, and she is the 61st woman to fly in space. Learn five things you may not know about Auñón-Chancellor in a profile video and an interview on Houston We Have a Podcast

Follow Auñón-Chancellor on her space mission at:

https://twitter.com/AstroSerena

SOURCE NASA


These press releases may also interest you

at 08:20
Coya Therapeutics, Inc. ("Coya" or the "Company"), a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell (Treg) function, announces that Dr. Stanley Appel, M.D., Chairman of Coya's Scientific Advisory...

at 08:05
Gilead Sciences, Inc. today announced the U.S. Food and Drug Administration (FDA) approved an updated label with additional data reinforcing the safety and efficacy profile of Biktarvy® (bictegravir 50 mg/emtricitabine 200 mg/tenofovir alafenamide...

at 08:05
Today, 2K announced TopSpin® 2K25, a revival of the beloved tennis simulation video game series developed by Hangar 13, is available now on PlayStation® 5 (PS5®), PlayStation®4 (PS4®), Xbox Series X|S, Xbox One, and PC via Steam. Featuring...

at 08:05
CPI Card Group Inc. ("CPI Card Group"), a payments technology company and leading provider of credit, debit, and prepaid card and digital solutions, including Software-as-a-Service-based instant issuance, today announced it will host a webcast and...

at 08:05
The European financial landscape saw a milestone event this week, as the EU Parliament passed the Amendment to Regulation (EU) No 575/2013, implementing the Basel III finalization within Europe. This monumental step forward comes with the adoption...

at 08:05
Medicenna Therapeutics Corp. ("Medicenna" or the "Company") (MDNAF: OTCQB), a clinical-stage immunotherapy company focused on the development of engineered cytokines, today announced a CA$20 million investment by RA Capital Management, a multi-stage...



News published on and distributed by: